Similar companies
| Company | X Mentions | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
36 29.4% |
 |
Eli Lilly and CompanyLLY |
60 11.8% |
 |
PfizerPFE |
86 5.5% |
 |
AstrazenecaAZN |
15 7.1% |
 |
AbbVieABBV |
42 5% |
Analyzing X Mentions, how is Aquestive Therapeutics performing compared to its industry peers?
Aquestive Therapeutics underperforms its industry peers when it comes to X Mentions, ranking in the 4th percentile.
Why should an investor track X mentions?
Investors should track mentions of Aquestive Therapeutics on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.
Sign up and get more insights on Aquestive Therapeutics.
Sentiment on X
The sentiment score for Aquestive Therapeutics on X is 63 (out of 100). This is considered neutral. Sentiment today is down compared to the 30 moving average.
